Literature DB >> 17109283

Interleukin-2: a potential treatment option for postherpetic neuralgia?

Jessica Rotty1, Lucie Heinzerling, Dirk Schurmann, Norbert Suttorp.   

Abstract

Postherpetic neuralgia is a chronic pain syndrome that is often difficult to treat and can lead to a disabling disease if it is resistant to therapy. Presented here is the case of a 46-year-old patient with human immunodeficiency virus infection and chronic, treatment-resistant neuralgia. Postherpetic pain resolved after treatment with 1 cycle of subcutaneous recombinant interleukin-2.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17109283     DOI: 10.1086/509639

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  2 in total

Review 1.  [Cytokine regulation and pain. Results of experimental and clinical research].

Authors:  N Uçeyler; C Sommer
Journal:  Schmerz       Date:  2008-12       Impact factor: 1.107

2.  Local and systemic cytokine expression in patients with postherpetic neuralgia.

Authors:  Nurcan Üçeyler; Michael Valet; Waldemar Kafke; Thomas R Tölle; Claudia Sommer
Journal:  PLoS One       Date:  2014-08-15       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.